Brief: Syros Reports Q1 2023 Financial Results And Provides A Corporate Update

Syros Pharmaceuticals

10/05/2023 12:41

May 10 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES
A CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.85
    * Q1 EARNINGS PER SHARE VIEW $-1.09 -- REFINITIV IBES DATA
    * ON TRACK TO COMPLETE ENROLLMENT OF 190 PATIENTS IN 4Q,
WITH
PIVOTAL COMPLETE RESPONSE DATA FROM SELECT-MDS-1 EXPECTED IN 3Q
2024
    * EXISTING CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES TO
FUND
OPERATING EXPENSES & CAPEX REQUIREMENTS INTO 2025
    * QTRLY REVENUES WERE $3.0 MILLION
    * Q1 REVENUE VIEW $3.3 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw6PhW1La 
Further company coverage:  SYRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))